Participated · Equity · Dec 2016

MedNet Solutions provides a SaaS-based eClinical technology platform, iMedNet, that supports the entire spectrum of clinical research and aims to improve the efficiency of studies and registries. The company serves pharmaceutical, medical device, biotechnology firms and contract research organizations around the world. MedNet was founded in 2001 and is led by President and CEO John M. (Rob) Robertson. In its second round of funding the company raised $16.5m, led by Arrowroot Capital with participation from new investor Cohesive Capital Partners and existing backers. The company intends to use the proceeds to accelerate the continued growth of its solutions. MedNet Solutions is a global life sciences technology company based in Minnetonka, MN, that builds electronic data capture (EDC) and clinical study management systems. Its flagship product is iMedNet EDC, a cloud-based eClinical platform that lets clinical research professionals rapidly design and run studies. The company describes iMedNet EDC as powerful, flexible and easy-to-use, with demonstrated traction among CROs and sponsors across all phases and therapeutic areas. MedNet has been operating since 2001 and supports clinical study initiatives worldwide. Management plans to use outside funding to support ongoing growth and further development of MedNet and its iMedNet EDC platform.